222

BIOCYTOGEN PHARMACEUTICALS (BEIJING

No trades
See on Supercharts

2315 fundamentals

BIOCYTOGEN PHARMACEUTICALS (BEIJING earnings per share and revenue

2315 earnings per share for the last semiannual are -0.53 HKD whereas the estimation was -0.48 HKD which accounts for -9.09% surprise. Company revenue for the same period amounts to 429.14 M HKD despite the estimated figure of 404.55 M HKD. Estimated earnings per share for the next semiannual are -0.40 HKD, and revenue is expected to reach 428.61 M HKD. Also watch annual changes over time to get a bigger picture of 2315 earnings per share and revenue dynamics.

Next report date
Report period
EPS estimate
Revenue estimate
EPS
‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Revenue
‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise